Source: https://www.law.cornell.edu/cfr/text/21/part-524
Timestamp: 2019-04-19 22:26:19+00:00

Document:
§ 524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
§ 524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
§ 524.390 Chloramphenicol ophthalmic ointment.
§ 524.575 Cyclosporine ophthalmic ointment.
§ 524.775 Emodepside and praziquantel.
§ 524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
§ 524.815 Eprinomectin and praziquantel.
§ 524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
§ 524.957 Florfenicol, terbinafine, and mometasone otic solution.
§ 524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.
§ 524.981c Fluocinolone and neomycin cream.
§ 524.981d Fluocinolone and dimethyl sulfoxide solution.
§ 524.981e Fluocinolone and dimethyl sulfoxide otic solution.
§ 524.1044 Gentamicin ophthalmic and topical dosage forms.
§ 524.1044a Gentamicin ophthalmic solution.
§ 524.1044b Gentamicin and betamethasone otic solution.
§ 524.1044c Gentamicin ophthalmic ointment.
§ 524.1044d Gentamicin and betamethasone ointment.
§ 524.1044f Gentamicin and betamethasone spray.
§ 524.1044g Gentamicin, betamethasone, and clotrimazole ointment.
§ 524.1044h Gentamicin, mometasone, and clotrimazole otic suspension.
§ 524.1044i Gentamicin and betamethasone ophthalmic solution.
§ 524.1132 Hydrocortisone, miconazole, and gentamicin otic suspension.
§ 524.1140 Imidacloprid and ivermectin.
§ 524.1146 Imidacloprid and moxidectin.
§ 524.1193 Ivermectin topical solution.
§ 524.1195 Ivermectin otic suspension.
§ 524.1200 Kanamycin ophthalmic and topical dosage forms.
§ 524.1200a Kanamycin ophthalmic ointment.
§ 524.1200b Kanamycin ophthalmic solution.
§ 524.1204 Kanamycin, amphomycin, and hydrocortisone ointment.
§ 524.1445 Miconazole, polymixin B, and prednisolone suspension.
§ 524.1446 Milbemycin otic solution.
§ 524.1448 Mirtazapine transdermal ointment.
§ 524.1484 Neomycin ophthalmic and topical dosage forms.
§ 524.1484b Neomycin, isoflupredone, tetracaine, and myristyl-gamma-picolinium powder.
§ 524.1484c Neomycin, isoflupredone, and tetracaine ointment.
§ 524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment.
§ 524.1484e Neomycin and polymyxin B ophthalmic solution.
§ 524.1484f Neomycin, prednisolone, and tetracaine otic suspension.
§ 524.1484g Neomycin, thiabendazole, and dexamethasone solution.
§ 524.1484h Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
§ 524.1484i Neomycin and hydrocortisone ointment.
§ 524.1484j Neomycin and prednisolone ophthalmic ointment.
§ 524.1484k Neomycin and prednisolone suspension.
§ 524.1580 Nitrofurazone topical dosage forms.
§ 524.1580b Nitrofurazone soluble powder.
§ 524.1580c Nitrofurazone and butacaine ointment.
§ 524.1600 Nystatin ophthalmic and topical dosage forms.
§ 524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
§ 524.1600b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
§ 524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
§ 524.1662 Oxytetracycline ophthalmic and topical dosage forms.
§ 524.1662a Oxytetracycline and hydrocortisone spray.
§ 524.1662b Oxytetracycline and polymyxin B ophthalmic ointment.
§ 524.1742 N-(Mercaptomethyl) phthalimide S-(O,O-dimethyl phosphorodithioate) emulsifiable liquid.
§ 524.1982 Proparacaine ophthalmic solution.
§ 524.2099 Selamectin and sarolaner.
§ 524.2101 Selenium disulfide suspension.
§ 524.2620 Liquid crystalline trypsin, Peru balsam, castor oil.
40 FR 13873, Mar. 27, 1975, unless otherwise noted.

References: § 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524

§ 524